Penn researchers say their study is first to show long-term effects of antimicrobial drugs on skin microbiome.
OncoResponse will use Theraclone’s I-STAR™ immune repertoire screening technology to identify therapeutic antibodies against new targets
Researchers at St. Louis University say they have discovered new information about how antibiotics like azithromycin stop staph infections, and why staph sometimes becomes resistant to drugs.
Johns Hopkins University engineers report using a non-invasive optical probe to understand the complex changes in tumors after immunotherapy. The research team’s approach combines detailed mapping of the biochemical composition of tumors with Raman spectroscopy and machine learning.
Computer method developed to generate many small proteins that can be designed to bind to therapeutic targets
Study results indicate that a previously uncharacterized 54 amino acid microprotein called PIGBOS sits on the outer mitochondrial membrane and plays a key role in modulating the unfolded protein response, or UPR, which mitigates a form of cellular stress. Dysregulation of UPR is thought to underpin a range of diseases including Alzheimer's disease and other neurodegenerative disorders.